输血前不规则抗体筛选的临床应用  

Clinical Application of Irregular Antibody Screening Before Blood Transfusion

作　　者：管占伟[1] 

机构地区：[1]新疆生产建设兵团第二师焉耆医院输血科,新疆库尔勒841100

出　　处：《中国医药指南》2016年第7期66-67,共2页Guide of China Medicine

摘　　要：目的探讨输血前不规则抗体筛选的临床应用价值。方法 2013年10月至2015年6月选择在我院进行输血的患者2800例,都进行输血前不规则抗体的筛选。结果在2800例患者中,不规则抗体筛选出阳性22例,阳性率为7.9%,其中男性6例,女性16例,有输血史者7例,同时有妊娠史和输血史者3例。在22例阳性患者中,在抗体特异性方面,其中抗-E抗体6例,抗-C抗体3例,抗-M抗体4例,自身抗体4例,其他抗体5例。结论输血前不规则抗体筛选的临床应用可及时检出患者体内的血型免疫型抗体,提前寻找相合的血液进行输血,从而有效保障输血安全。Objective To discuss the clinical application of irregular antibody screening before blood transfusion. Methods 2800 patients with blood transfusion in our hospital were selected from October 2013 to June 2015. The screening of irregular antibodies before blood transfusion was carried out. Results In 2800 cases, irregular antibody screening positive with 22 cases, positive rate was 7.9%, which 6 cases of male, 16 cases of female, 7 cases had history of blood transfusion, and history of blood transfusion and pregnancy in 3 cases. 22 cases of positive patients, including anti-E antibodies in 6 cases, anti-C antibodies in 3 cases, anti-M antibodies in 4 cases, autoantibodies in 4 cases, other antibodies in 5 cases. Conclusion The clinical application of irregular antibody screening before blood transfusion can detect the blood type immune antibody in patients in time, look ahead the consistency of blood for transfusion, so as to ensure the safety of blood transfusion.

关 键 词：输血 不规则抗体 抗体筛选 

分 类 号：R446.6[医药卫生—诊断学]